Skip to main content

Generation of Recombinant Capripoxvirus Vectors for Vaccines and Gene Knockout Function Studies

  • Protocol
Vaccine Technologies for Veterinary Viral Diseases

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1349))

Abstract

The ability to manipulate capripoxvirus through gene knockouts and gene insertions has become an increasingly valuable research tool in elucidating the function of individual genes of capripoxvirus, as well as in the development of capripoxvirus-based recombinant vaccines. The homologous recombination technique is used to generate capripoxvirus knockout viruses (KO), and is based on the targeting a particular viral gene of interest. This technique can also be used to insert a gene of interest. A protocol for the generation of a viral gene knockout is described. This technique involves the use of a plasmid which encodes the flanking sequences of the regions where the homologous recombination will occur, and will result in the insertion of an EGFP reporter gene for visualization of recombinant virus, as well as the E. coli gpt gene as a positive selection marker. If an additional gene is to be incorporated, this can be achieved by inserting a gene of interest for expression under a poxvirus promoter into the plasmid between the flanking regions for insertion. This chapter describes a protocol for generating such recombinant capripoxviruses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Boshra H, Truong T, Nfon C et al (2013) Capripoxvirus-vectored vaccines against livestock diseases in Africa. Antiviral Res. doi:10.1016/j.antiviral.2013.02.016

    PubMed  Google Scholar 

  2. Tulman ER, Afonso CL, Lu Z et al (2001) Genome of lumpy skin disease virus. J Virol 75:7122–7130. doi:10.1128/JVI.75.15.7122-7130.2001

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Tulman ER, Afonso CL, Lu Z et al (2002) The genomes of sheeppox and goatpox viruses. J Virol 76:6054–6061

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Babiuk S, Bowden TR, Boyle DB et al (2008) Capripoxviruses: an emerging worldwide threat to sheep, goats and cattle. Transbound Emerg Dis 55:263–272. doi:10.1111/j.1865-1682.2008.01043.x

    Article  CAS  PubMed  Google Scholar 

  5. Bhanuprakash V, Indrani BK, Hosamani M et al (2006) The current status of sheep pox disease. Comp Immunol Microbiol Infect Dis 29:27–60. doi:10.1016/j.cimid.2005.12.001

    Article  CAS  PubMed  Google Scholar 

  6. Bowden TR, Babiuk SL, Parkyn GR et al (2008) Capripoxvirus tissue tropism and shedding: a quantitative study in experimentally infected sheep and goats. Virology 371:380–393. doi:10.1016/j.virol.2007.10.002

    Article  CAS  PubMed  Google Scholar 

  7. African Union International Bureau for Animal Resources (2012) Impact of livestock diseases in Africa, May

    Google Scholar 

  8. Davies FG, Mbugwa G (1985) The alterations in pathogenicity and immunogenicity of a Kenya sheep and goat pox virus on serial passage in bovine foetal muscle cell cultures. J Comp Pathol 95:565–572

    Article  CAS  PubMed  Google Scholar 

  9. Kitching RP (2003) Vaccines for lumpy skin disease, sheep pox and goat pox. Dev Biol (Basel) 114:161–167

    CAS  Google Scholar 

  10. Johnston JB, McFadden G (2004) Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes. Cell Microbiol 6:695–705. doi:10.1111/j.1462-5822.2004.00423.x

    Article  CAS  PubMed  Google Scholar 

  11. Balinsky CA, Delhon G, Afonso CL et al (2007) Sheeppox virus kelch-like gene SPPV-019 affects virus virulence. J Virol 81:11392–11401, JVI.01093-07 [pii]

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Perrin A, Albina E, Breard E et al (2007) Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants. Vaccine 25:6774–6783. doi:10.1016/j.vaccine.2007.06.052

    Article  CAS  PubMed  Google Scholar 

  13. Wade-Evans AM, Romero CH, Mellor P et al (1996) Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge. Virology 220:227–231. doi:10.1006/viro.1996.0306

    Article  CAS  PubMed  Google Scholar 

  14. Soi RK, Rurangirwa FR, McGuire TC et al (2010) Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine. Clin Vaccine Immunol 17:1842–1849

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Wallace DB, Ellis CE, Espach A et al (2006) Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. Vaccine 24:7181–7189. doi:10.1016/j.vaccine.2006.06.041, S0264-410X(06)00769-9 [pii]

    Article  CAS  PubMed  Google Scholar 

  16. Romero CH, Barrett T, Kitching RP et al (1995) Protection of goats against peste des petits ruminants with recombinant capripoxviruses expressing the fusion and haemagglutinin protein genes of rinderpest virus. Vaccine 13:36–40

    Article  CAS  PubMed  Google Scholar 

  17. Romero CH, Barrett T, Kitching RP et al (1994) Protection of cattle against rinderpest and lumpy skin disease with a recombinant capripoxvirus expressing the fusion protein gene of rinderpest virus. Vet Rec 135:152–154

    Article  CAS  PubMed  Google Scholar 

  18. Romero CH, Barrett T, Chamberlain RW et al (1994) Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses. Virology 204:425–429. doi:10.1006/viro.1994.1548

    Article  CAS  PubMed  Google Scholar 

  19. Romero CH, Barrett T, Evans SA et al (1993) Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease. Vaccine 11:737–742

    Article  CAS  PubMed  Google Scholar 

  20. Mulligan RC, Berg P (1981) Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc Natl Acad Sci U S A 78:2072–2076

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shawn Babiuk .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this protocol

Cite this protocol

Boshra, H., Cao, J., Babiuk, S. (2016). Generation of Recombinant Capripoxvirus Vectors for Vaccines and Gene Knockout Function Studies. In: Brun, A. (eds) Vaccine Technologies for Veterinary Viral Diseases. Methods in Molecular Biology, vol 1349. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3008-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3008-1_10

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-3007-4

  • Online ISBN: 978-1-4939-3008-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics